通络祛痛膏治疗膝骨关节炎疗效与安全性研究:随机双盲平行阳性对照多中心临床试验方案
本研究为随机、双盲、平行阳性对照、多中心非劣效性临床试验,计划纳入2000例40岁以上膝骨关节炎患者,按3:1随机分为试验组1500例与对照组500例。两组均接受为期14天、每日一次、共两个疗程的常规保守治疗,试验组外用通络祛痛膏,对照组外用奇正消痛膏,于基线和1周、2周随访时评估西安大略和麦克马斯特大学骨关节炎指数总分、中医证候量化评分和视觉模拟量表评分,并记录不良事件。
要点
- 计划纳入2000例40岁以上膝骨关节炎患者,试验组1500例用通络祛痛膏,对照组500例用奇正消痛膏。
- 两组均接受14天、每日一次、共两个疗程的常规保守治疗。
- 主要评估指标为西安大略和麦克马斯特大学骨关节炎指数总分、中医证候量化评分和视觉模拟量表评分。
核心结论
- 本研究旨在评估通络祛痛膏治疗膝骨关节炎的疗效和安全性,若结果有利,膝骨关节炎患者可能获得一种良好的替代治疗。
研究设计与样本
- 随机、双盲、平行阳性对照、多中心临床试验,采用非劣效性试验设计。
- 计划纳入2000例40岁以上膝骨关节炎患者,随机分为试验组1500例和对照组500例。
- 两组均接受为期14天、每日一次、共两个疗程的常规保守治疗。
- 试验组外用通络祛痛膏,对照组外用奇正消痛膏。
- 于基线及1周、2周随访时评估西安大略和麦克马斯特大学骨关节炎指数总分、中医证候量化评分和视觉模拟量表评分,并记录不良事件。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Knee osteoarthritis (KOA) is a common chronic musculoskeletal disorder that seriously affects quality of life. Patients with KOA frequently develop one or more of the following typical symptoms: joint pain, stiffness, joint friction noise and impaired functionality. Traditional Chinese medicine (TCM) has been shown to have a superior effect and a particular advantage in the treatment of KOA; among TCM, the Tong-luo Qu-tong plaster is the convenient and most commonly used method in China to improve symptoms including pain, stiffness and limited mobility in patients with KOA, as it causes few adverse effects. But there is a lack of high-quality clinical evidences to support the therapeutic effect that Chinese adhesive plaster can have in relieving pain and stiffness. The purpose of this study will be to evaluate the efficacy and safety of Tong-luo Qu-tong plaster in patients with KOA. METHODS/DESIGN: This study will be a randomized, double-blind, parallel positive controlled, multi-center clinical trial, a non-inferiority trial design was adopted. A total of 2000 participants older than 40 years, with KOA, will be randomly allocated into an experimental group (n = 1500) and a control group (n = 500). All participants will receive a conventional conservative treatment lasting for 14 days as two courses, once daily. Tong-luo Qu-tong plaster will be administered externally to participants in the experimental group, while the control group will receive a Qi-zheng Xiao-tong plaster. The outcome of the total Western Ontario and McMaster Universities Arthritis Index scores, TCM syndrome quantitative score and visual analog scale scores will be measured during the assessment visits (baseline and 1-week and 2-week follow up). In addition, adverse events related to clinical symptoms and signs and results of laboratory tests will be documented during the clinical trials. DISCUSSION: This study will provide reliable evidence of the effectiveness and safety of Tong-luo Qutong plaster in patients with KOA. If the results are favorable, it is expected that the patients with KOA will benefit from this study, many patients may have a good alternative treatment for KOA. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03309501 . Registered on 8 November 2017.
引用
- Xu BP, Yao M, Tian ZR, et al. Study on efficacy and safety of Tong-luo Qu-tong plaster treatment for knee osteoarthritis: study protocol for a randomized, double-blind, parallel positive controlled, multi-center clinical trial. Trials. 2019. PMID: 31234919. doi:10.1186/s13063-019-3481-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。